The company found some relief after adding GLP-1 obesity treatment offerings in 2023, but still hasnt strayed from the more traditional approach to weight loss, focusing on food intake and behavioral changes
These factors could have confounded our findings
Full fact check inside
However, it is accepted that visceral adiposity, insulin resistance, T2D, hypertension, and dyslipidemia are significant contributors to NAFLD development 7
This combination of higher achievable plasma levels and better tolerability explains why vitamin C is a core ingredient in immune, recovery, and skinfocused IV drips
Still, some patients struggle to access the drugs due to the spotty insurance coverage of weight loss treatments in the U.S